Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

uPA-mediated remodeling of CCL21 gradients regulates lymphatic migration of dendritic cells.

The Journal of cell biology·2026

Same author

Bioengineered Lymphatic Vessels in Synthetic Matrices to Study Breast Cancer Cell Functions.

Advanced healthcare materials·2026

Same author

Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization.

Nature communications·2025

Same author

Transcriptomics- and 3D imaging-based characterization of the lymphatic vasculature in human skin.

The Journal of experimental medicine·2025

Same author

Lymph nodes fuel KLF2-dependent effector CD8<sup>+</sup> T cell differentiation during chronic infection and checkpoint blockade.

Nature immunology·2025

Same author

Author Correction: Computer-assisted quantification of motile and invasive capabilities of cancer cells.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: Apr 8, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Multidimensional Design of Anticancer Peptides.

Yen-Chu Lin¹, Yi Fan Lim¹, Erica Russo¹

¹Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Vladimir-Prelog-Weg 4, 8093 Zurich (Switzerland).

Angewandte Chemie (International Ed. in English)

|June 30, 2015

Summary

This summary is machine-generated.

Computer-aided design created novel anticancer peptides by combining cell-penetrating and tumor-homing features. These optimized peptides selectively kill cancer cells and enhance chemotherapy efficacy in vitro.

Keywords:

cancer drug discovery lipid membranes machine learning molecular design

More Related Videos

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Published on: September 19, 2022

Related Experiment Videos

Last Updated: Apr 8, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids

Published on: May 3, 2024

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers

Published on: September 19, 2022

Area of Science:

Biochemistry
Computational Biology
Oncology

Background:

Developing targeted cancer therapies is crucial for improving patient outcomes.
Anticancer peptides (ACPs), cell-penetrating peptides (CPPs), and tumor-homing peptides (THPs) offer unique therapeutic properties.
Integrating these peptide functionalities could lead to more effective cancer treatments.

Purpose of the Study:

To design and optimize peptides with selective cancer cell-killing activity.
To leverage machine learning for identifying candidate peptides with desired properties.
To enhance peptide efficacy in cancer treatment and reduce side effects.

Main Methods:

Utilized computer-assisted design integrating ACP, CPP, and THP features.
Employed machine-learning classifiers to identify and predict peptide properties.
Systematically optimized peptide sequences for cytotoxicity against cancer cell lines.
Minimized effects on primary human endothelial cells to assess selectivity.

Main Results:

Generated computer-designed peptide sequences with enhanced cancer cell penetration.
Demonstrated induced apoptosis in cancer cells by the designed peptides.
Showcased a reduction in the required concentration of co-administered chemotherapeutic agents in vitro.
Achieved selective cytotoxicity against cancer cell lines while sparing normal cells.

Conclusions:

Multidimensional machine-learning methods are effective for rapid peptide design.
The developed peptides exhibit promising selective anticancer activity.
This approach holds potential for developing next-generation cancer therapeutics.